ORCID as entered in ROS

Select Publications
Ritter A, 2022, Drug Policy, Routledge, Abingdon, http://dx.doi.org/10.4324/9781003224501
Roxburgh AD; Ritter A; Slade T; Burns L, 2014, Trends in Drug Use and Related Harms in Australia, 2001 to 2013, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, http://ndarc.med.unsw.edu.au/resource/trends-drug-use-and-related-harms-australia
Ritter A; King T; Hamilton M, 2013, Drug Use in Australian Society, Ritter A; King T; Lee N, (eds.), 1, Oxford University Press, Australia, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863
Ritter A; Lancaster K; Grech K; Reuter P, 2011, An assessment of illicit drug policy in Australia (1985 to 2010): Themes and trends, Original, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia, http://www.dpmp.unsw.edu.au/DPMPWeb.nsf/resources/monograph1.pdf/$file/DPMP+MONO+21.pdf
Roxburgh AD; Ritter A; Grech K; Slade T; Burns LA, 2011, Trends in Drug Use and Related Harms in Australia, 2001 to 2011, Original, Drug Policy Modelling Program, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, http://ndarc.med.unsw.edu.au/resource/trends-drug-use-and-related-harms-australia-2001-2011-0
King T; Ritter A; Berends L, 2011, Victorian pharmacotherapy review, Original, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW
Chalmers JJ; Ritter A; Heffernan M; McDonnell GD, 2009, Modelling pharmacotherapy maintenance in Australia: Exploring affordability, availability, accessibility and quality using system dynamics., 1, Australian National Council on Drugs, Canberra
Ritter A; Chalmers JJ, 2009, Polygon: The many sides to the Australian opioid pharmacotherapy maintenance system, 1, Australian National Council on Drugs, Canberra
Ross JE; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R, 2004, Twelve Month Outcomes of Treatment for Heroin Dependence Findings from the Australian Treatment Outcome Study (ATOS), NDARC Technical Report No. 196, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
Barrett L; Ritter A; Lancaster K; Seear K, 2021, 'Stigma and discrimination', in Haber P; Riordan B (ed.), Guidelines for the Treatment of Alcohol Problems, Specialty of Addiction Medicine, Faculty of Medicine and Health, The University of Sydney., Sydney, pp. 31 - 36, https://alcoholtreatmentguidelines.com.au/pdf/guidelines-for-the-treatment-of-alcohol-problems.pdf
Ritter A; Lancaster KS, 2018, 'Multiple Streams', in Hoppe R; Colebatch H (ed.), Handbook on the Policy, Process and Governing, Edward Elgar, Cheltenham, pp. 232 - 252, http://dx.doi.org/10.4337/9781784714871.00021
Nielsen S; Gisev N, 2017, 'Drug Pharmacology and Pharmacotherapy Treatments', in Ritter A; King T; Lee N (ed.), Drug Use and Australian Society 2nd Edition, edn. 2nd, OUP
McDonald D; Hughes CE, 2017, 'Chapter 11: Drug laws and regulations', in Ritter A; King T; Lee N (ed.), Drug Use in Australian Society, edn. 2nd, Oxford University Press, South Melbourne, pp. 223 - 246
Ritter A; Lancaster KS, 2017, 'Making Drugs Policy: Policy Models and Influences on Policy Processes', in Ritter A; Trevor K; Lee N (ed.), Drug Use in Australian Society, Oxford University Press, South Melbourne, Victoria, pp. 266 - 291, https://www.oup.com.au/books/higher-education/health,-nursing-and-social-work/9780190306458-drug-use-in-australian-society
Ritter A; Chalmers J; Berends L, 2017, 'A methodology for estimating health expenditure on drug treatment: the Australian experience', in Drug treatment expenditure: a methodological overview, European Monitoring Centre for Drugs and Drug Addiction, Luxembourg, pp. 25 - 34, http://dx.doi.org/10.2810/052028
Barratt MJ; Lenton S, 2017, 'Drugs and the internet', in Ritter A; King T; Lee N (ed.), Drug Use in Australian Society, Oxford University Press Australia, pp. 102 - 123
Ritter A; King T; Lee N, 2017, 'Introduction', in Ritter A; King T; Lee N (ed.), Drug Use in Australian Society, edn. 2nd, Oxford University Press Australia, Melbourne, pp. 1 - 19
Champion K; Newton N; Birrell LE; Teesson M, 2017, 'Primary Prevention for Alcohol and Other Drug Use among Australian Adolescents', in Ritter A; Lee N; King T (ed.), Drug Use in Australian Society, Oxford University Press Australia, pp. 124 - 143
Ritter A; Hughes CE; Hull P, 2016, 'Drug policy', in Kolind T; Thom B; Hunt G; Karch S; Thom B; White J (ed.), The SAGE handbook of drug & alcohol studies. Volume 1, Social science approaches, SAGE, Thousand Oaks, CA, pp. 135 - 163
Ritter A, 2013, 'I2S Needs Theory as Well as a Toolkit', in Bammer G (ed.), Disciplining Interdisciplinarity: Integration and Implementation Sciences for Researching Complex Real-World Problems, ANU E Press, Canberra, ACT, pp. 313 - 318, http://epress.anu.edu.au/wp-content/uploads/2013/01/whole.pdf#page=337
Ritter A; Lancaster K, 2013, 'Policy models and influences on policy processes', in Ritter A; King T; Hamilton M (ed.), Drug Use in Australian Society, edn. 1, Oxford University Press, Australia, pp. 99 - 132, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863
King T; Ritter A; Hamilton M, 2013, 'Setting the scene', in Ritter A; King T; Hamilton M (ed.), Drug Use in Australian Society, edn. Military Strategy and Operational Art, Oxford University Press, Australia, pp. 3 - 26, http://www.oup.com.au/titles/higher_ed/health_sciences/9780195518863
Ritter A, 2011, 'Australia', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 75 - 77, http://www.uk.sagepub.com/books/Book234211
Ritter A, 2011, 'Drug Treatment Programs', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 247 - 250, http://www.uk.sagepub.com/books/Book234211
Ritter A, 2011, 'Methadone', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 506 - 508, http://www.uk.sagepub.com/books/Book234211
Ritter A, 2011, 'Needle Exchange Programs', in Kleiman MAR; Hawdon JE (ed.), Encyclopedia of Drug Policy, edn. Original, SAGE Publications, Thousand Oaks, California, pp. 563 - 565, http://www.uk.sagepub.com/books/Book234211
Bammer G; Strazdins L; McDonald D; Berry H; Ritter A; Deane P; van Kerkhoff L, 2010, 'Expanding the deliberations about the research-policy gap: useful ideas from the literature', in Bammer G; Michaux A; Sanson A (ed.), BRIDGING THE KNOW-DO GAP: KNOWLEDGE BROKERING TO IMPROVE CHILD WELLBEING, ANU E Press, Canberra, Australia, pp. 135 - 155, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291465600012&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Henry-Edwards S; Gowing L; White J; Ali RL; Lintzeris N; Bell JR; Ritter A; Quigley A, 2009, 'Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 354 - 389
Bell JR; Kimber J; Lintzeris N; White J; Mattick RP; Ritter A, 2009, 'Clinical guidelines and procedures for the use of naltrexone in the opioid dependence.', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 446 - 474
Gibson AE; Ritter A, 2009, 'Naltrexone maintenance treatment', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 252 - 281
Lintzeris N; Clark N; Muhleisen P; Ritter A; Mattick RP, 2009, 'National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence.', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 390 - 445
Dunlop A; Petroulias D; Marope D; Khoo K; Kimber J; Ritter A; Burrell T; Osborn DA, 2009, 'Pharmacotherapies and pregnancy', in Mattick RP; Ali R; Lintzeris N (ed.), Pharmacotherapies for Opioid Dependence Treatment, edn. 1, Informa Healthcare, London, UK, pp. 282 - 329
Smithson M; Bammer G; Ritter A, 2008, 'Coping and manageing under uncertainty', in Uncertainty metaphors, motives and morals., Earthscan, London, pp. 321 - 333, http://dx.doi.org/10.4324/9781849773607
Dray A; Mazerolle L; Perez P; Ritter A, 2008, 'Drug law enforcement in an agent-based model:Simulating the disruption to street-level drug markets', in Liu L; Eck J (ed.), Artificial crime analysis systems: using computer simulations and geographic information systems, Idea Group Publishing, Hershey, PA, pp. 352 - 371, http://dx.doi.org/10.4018/978-1-59904-591-7.ch018
Ritter A, 2008, 'Heroin: Injected with uncertainty.', in Brammer G; Smithson M (ed.), Uncertainty: Mutidisciplinary perspectives on risk, Earthscan, London, pp. 157 - 169, http://dx.doi.org/10.4324/9781849773607
Bammer G; Smithson M; Ritter A, 2008, 'The nature of uncertainty', in Bammer G; Smithson M (ed.), Uncertainty and Risk; Multidisciplinary Perspectives, Earthscan Publications, UK, pp. 289 - 303, http://dx.doi.org/10.4324/9781849773607
Smithson M; Bammer G; Ritter A, 2008, 'Uncertainty metaphors, motives and morals.', in Bammer G; Smithson M (ed.), Uncertainty and Risk; Multidisciplinary Perspectives, Earthscan Publications, UK, pp. 305 - 320, http://dx.doi.org/10.4324/9781849773607
Perez P; Dray A; Ritter A; Dietze P; Moore T; Mazerolle L, 2006, 'SimDrug: A Multi-Agent System Tackling the Complexity of Illicit Drug Markets in Australia', in Perez P; Batten D (ed.), COMPLEX SCIENCE FOR A COMPLEX WORLD: EXPLORING HUMAN ECOSYSTEMS WITH AGENTS, AUSTRALIAN NATL UNIV, pp. 193 - 223, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000291158700015&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Bowden SC; Ritter AJ, 2005, 'Alcohol-related dementia and the clinical spectrum of Wernicke-Korsakoff syndrome', in Dementia 3Ed, pp. 738 - 744
Kowalski M; Wilkinson C; Livingston M; Ritter A, 2023, 'Piloting a classification framework for the types of evidence used in alcohol policymaking.', Drug Alcohol Rev, http://dx.doi.org/10.1111/dar.13599
Stirling R; Nathan S; Ritter A, 2023, 'Prioritizing measures to assess performance of drug treatment services: a Delphi process with funders, treatment providers and service-users', Addiction, vol. 118, pp. 119 - 127, http://dx.doi.org/10.1111/add.16038
McLauchlan L; Lancaster K; Kearnes M; Mellor R; Ritter A, 2022, '“It's professional but it's personal”: Participation, personal connection, and sustained disagreement in drug policy reform', International Journal of Drug Policy, vol. 110, pp. 103903 - 103903, http://dx.doi.org/10.1016/j.drugpo.2022.103903
Mellor R; Kearnes M; Lancaster K; McLauchlan L; Ritter A, 2022, 'Established Tables and Emergent Huddles: Exploring the Processes of Participation Associated With the Policy Changes to Opioid Pharmacotherapy Treatment in Australia in the Context of COVID-19', Contemporary Drug Problems, vol. 49, pp. 385 - 404, http://dx.doi.org/10.1177/00914509221123001
Barrett L; Mellor R; Ritter A; McLauchlan L; Kearnes M, 2022, 'Navigating the grey: Experiences of incremental cannabis reform in Australia', Drug and Alcohol Review, vol. 41, pp. 1621 - 1629, http://dx.doi.org/10.1111/dar.13518
Ritter A, 2022, 'Words matter: A commentary on the new UK drug strategy', International Journal of Drug Policy, vol. 109, pp. 103846 - 103846, http://dx.doi.org/10.1016/j.drugpo.2022.103846
Vuong T; Gillies M; Larney S; Montebello M; Ritter A, 2022, 'The association between involuntary alcohol treatment and subsequent emergency department visits and hospitalizations: a Bayesian analysis of treated patients and matched controls', Addiction, vol. 117, pp. 1589 - 1597, http://dx.doi.org/10.1111/add.15755
O'Reilly K; Kowalski M; Barratt MJ; Ritter A, 2022, 'Distinguishing personal use of drugs from drug supply: Approaches and challenges', International Journal of Drug Policy, vol. 103, pp. 103653, http://dx.doi.org/10.1016/j.drugpo.2022.103653
Curchin K; Weight T; Ritter A, 2022, 'Moral framings in the Australian parliamentary debate on drug testing of welfare recipients', Social Policy and Administration, vol. 56, pp. 409 - 422, http://dx.doi.org/10.1111/spol.12774
Ritter A; van de Ven K; Vuong T; Chalmers J; Dobbins T; Livingston M; Berends L, 2022, 'Are market mechanisms associated with alcohol and other drug treatment outcomes?', Addiction, vol. 117, pp. 1105 - 1116, http://dx.doi.org/10.1111/add.15681
Greer A; Bonn M; Shane C; Stevens A; Tousenard N; Ritter A, 2022, 'The details of decriminalization: Designing a non-criminal response to the possession of drugs for personal use', International Journal of Drug Policy, vol. 102, http://dx.doi.org/10.1016/j.drugpo.2022.103605